Abatacept in Early Diffuse Cutaneous Systemic Sclerosis – Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial

OBJECTIVES: T cells play a key role in the pathogenesis of early systemic sclerosis. This study assessed the safety and efficacy of abatacept in patients with diffuse cutaneous systemic sclerosis (dcSSc). METHODS: A 12-month, randomized, double-blind, placebo-controlled trial with participants rando...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arthritis Rheumatol
Hoofdauteurs: Khanna, Dinesh, Spino, Cathie, Johnson, Sindhu, Chung, Lorinda, Whitfield, Michael, Denton, Christopher P., Berrocal, Veronica, Jennifer, Franks, Mehta, Bhaven, Molitor, Jerry, Steen, Virginia D., Lafyatis, Robert, Simms, Robert W., Gill, Anna, Kafaja, Suzanne, Frech, Tracy M., Hsu, Vivien, Domsic, Robyn T., Pope, Janet E., Gordon, Jessica K., Mayes, Maureen D., Schiopu, Elena, Young, Amber, Sandorfi, Nora, Park, Jane, Hant, Faye N., Bernstein, Elana J., Chatterjee, Soumya, Castelino, Flavia V., Ajam, Ali, Wang, Yue, Wood, Tammara, Allanore, Yannick, Matucci-Cerinic, Marco, Distler, Oliver, Singer, Ora, Bush, Erica, Fox, David, Furst, Daniel E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935399/
https://ncbi.nlm.nih.gov/pubmed/31342624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41055
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items